The recent advances in cell delivery approaches, biochemical and engineering procedures of cell therapy applied to coronary heart disease - 04/12/23

Abstract |
Cell therapy is an important topic in the field of regeneration medicine that is gaining attention within the scientific community. However, its potential for treatment in coronary heart disease (CHD) has yet to be established. Several various strategies, types of cells, routes of distribution, and supporting procedures have been tried and refined to trigger heart rejuvenation in CHD. However, only a few of them result in a real considerable promise for clinical usage. In this review, we give an update on techniques and clinical studies of cell treatment as used to cure CHD that are now ongoing or have been completed in the previous five years. We also highlight the emerging efficacy of stem cell treatment for CHD. We specifically examine and comment on current breakthroughs in cell treatment applied to CHD, including the most effective types of cells, transport modalities, engineering, and biochemical approaches used in this context. We believe the current review will be helpful for the researcher to distill this information and design future studies to overcome the challenges faced by this revolutionary approach for CHD.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
● | Cell types and delivery techniques are reviewed for cardiac regeneration. |
● | Preclinical cell-based therapy is effective and has yielded encouraging results. |
● | Stem cells prevent cell death, promote angiogenesis, and improve cardiac function. |
● | Many fundamental puzzles for optimal drug delivery approach remain to be resolved. |
● | Limited cell engraftment, survival, and cell monitoring are not yet understood. |
Keywords : Cell therapy, Regeneration medicine, Coronary heart disease, Cell delivery approaches
Plan
Vol 169
Article 115870- décembre 2023 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?